Consolidated Statement Of Comprehensive Income

Carna Biosciences, Inc. - Filing #7345290

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-1,184,953,000 JPY
-1,184,953,000 JPY
-1,152,895,000 JPY
-1,184,953,000 JPY
-1,184,953,000 JPY
-1,405,357,000 JPY
-1,405,357,000 JPY
-1,349,539,000 JPY
-1,405,357,000 JPY
-1,405,357,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-349,000 JPY
-1,742,000 JPY
Deferred gains or losses on hedges
-615,000 JPY
-5,962,000 JPY
Foreign currency translation adjustment
18,483,000 JPY
25,384,000 JPY
Other comprehensive income
17,518,000 JPY
17,678,000 JPY
Comprehensive income
-1,135,377,000 JPY
-1,331,861,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-1,135,377,000 JPY
-1,331,861,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.